A urologic cancer-based study provided some mechanistic insight into VNN2’s impact, in which VNN2 was found to promote non-adhesive proliferation and IL-1beta production in prostate cancer cell lines and generally was correlated with poor survival outcomes [48]. The gene discussed is IL1B; the disease is prostate carcinoma.